Printer Friendly

Antipsychotic risks for the elderly.

Tardive dyskinesia (TD), a potentially debilitating movement disorder that can accompany the use of antipsychotic drugs (SN: 5/11/91, p.293), annually afflicts nearly one in three elderly people taking such medication, according to a report in the Nov. 6 JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. This represents about six times the annual rate of the new TD cases observed among younger people taking antipsychotics, the researchers note.

Psychiatrist Bruce L. Saltz of Long Island Jewish Medical Center in Glen Oaks, N.Y., and his co-workers tracked 160 patients, aged 57 years and older, who started antipsychotic treatment for the first time at six geriatric facilities or nursing homes in the New York City area. Follow-ups lasted an average of nine months. None of the participants suffered from neurological disorders that produce abnormal movements.

All TD cases appeared within 11 months of usually intermittent drug treatment, the investigators report. Individuals with mood disorders -- such as severe depression -- that included psychotic symptoms proved most vulnerable to TD.

Antipsychotic drugs decrease the availability of the neuro-transmitter dopamine in the brain. Saltz's team proposes that brain cells that process dopamine may naturally decrease in number and function as a person grows old, rendering the elderly more susceptible to TD as antipsychotic drugs further diminish dopamine supplies.

"Although almost all our TD cases were mild, some can be severe, even debilitating, and there is no way to predict who will develop the more severe forms," the researchers conclude.
COPYRIGHT 1991 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:tardive dyskinesia and antipsychotic drug use
Publication:Science News
Date:Nov 16, 1991
Previous Article:Prescription-law side effect.
Next Article:Privacy versus database statistics.

Related Articles
TD hazards among the retarded.
Rat model of tardive dyskinesia gets boost.
New report offers antipsychotic guidelines.
Antipsychotics evoke youthful concerns.
Antipsychotic drug doses climb over time.
Vitamin E may ease movement disorder.
Schizophrenia: promising drug ... and infectious clues.
Schizophrenia drugs: a case for tapering.
Dose of caution: new antipsychotic meds produce muted benefits. (Science News This Week).
Managing the risk of tardive dyskinesia: based on an interview with William M. Glazer, MD.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters